ArticleJournal of cancer research and clinical oncology2023

Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.

Jiaoquan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.